Abstract
The presence of tumor hypoxia is associated with poor patient outcome to cancer treatment, including radiation therapy and surgery. Hypoxia itself may indicate a more aggressive tumor phenotype, and tumor hypoxia has been associated with the probability of metastatic development. Numerous methods are available to quantify hypoxia, including polarographic needle probes (e.g., Eppendorf p02 histograph), fluorescence-based needle probes (e.g., OxyLite), the comet assay, and nitroimidazole-based hypoxia markers (e.g., pimonidazole, NITP, EF3, and EF5). A unique feature of hypoxia markers is that they permit the investigation of not only tumor-averaged hypoxia, but also the spatial distribution of oxygen within the biopsies sampled. Such data facilitate the investigation of the effects of intratumoral oxygen distribution on the microregional response to oxygen-dependent treatment modalities. For example, knowledge of the spatial distribution of oxygen is important in Photodynamic Therapy (PDT), which may target vascular-distant tumor cells, as well as the vascular endothelium itself. The present manuscript describes a Matlab-based image-processing program that we have developed for the quantitative analysis of the spatial distribution of tumor hypoxia, as labeled by the hypoxia markers EF3 or EF5.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D.M. Brizel, R.K. Dodge, R.W. Clough, and M.W. Dewhirst, Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome, Radiotherapy & Oncology. 53(2), 113–117 (1999).
M. Hockel, K. Schlenger, B. Aral, M. Mitze, U. Schaffer, and P. Vaupel, Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix, Cancer Res. 56(19), 4509–4515 (1996).
A.C. Koong, N.C. Denko, K.M. Hudson, C. Schindler, L. Swiersz, C. Koch, S. Evans, H. Ibrahim, Q.T. Le, D.J. Terris, and A.J. Giaccia, Candidate genes for the hypoxic tumor phenotype, Cancer Res. 60(4), 883–887 (2000).
D.M. Brizel, S.P. Scully, J.M. Harrelson, L.J. Layfield, J.M. Bean, L.R. Prosnitz, and M.W. Dewhirst, Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma, Cancer Res. 56(5), 941–943 (1996).
. P. Vaupel, K. Schlenger, C. Knoop, and M. Hockel, Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized 02 tension measurements, Cancer Res. 51(12), 3316–3322 (1991).
J. Bussink, J.H. Kaanders, A.M. Strik, B. Vojnovic, and A.J. van Der Kogel, Optical sensor-based oxygen tension measurements correspond with hypoxia marker binding in three human tumor xenograft lines, Radiat. Res. 154(5), 547–555 (2000).
P.L. Olive, R.E. Durand, J.A. Raleigh, C. Luo, and C. Aquino-Parsons, Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia, Br. J. Cancer. 83(11), 1525–1531 (2000).
P.F. Rijken, H.J. Bernsen, J.P. Peters, R.J. Hodgkiss, J.A. Raleigh, and A.J. van der Kogel, Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis, Int. J. Radiat. Oncol. Biol. Phys. 48(2), 571–582 (2000).
S.M. Evans, S. Hahn, D.R. Pook, W.T. Jenkins, A.A. Chalian, P. Zhang, C. Stevens, R. Weber, G. Weinstein, I. Benjamin, N. Mirza, M. Morgan, S. Rubin, W.G. McKenna, E.M. Lord, and C.J. Koch, Detection of hypoxia in human squamous cell carcinoma by EF5 binding, Cancer Res. 60(7), 2018–2024 (2000).
T.M. Busch, S.M. Hahn, S.M. Evans, and C.J. Koch, Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-nitroimidazol-1[H]-y1)-N-(3,3,3,- trifluoropropyl)acetamide], Cancer Res. 60, 2636–2642 (2000).
T.J. Dougherty, C.J. Gomer, B.W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan, and Q. Peng, Photodynamic therapy, J. Natl. Cancer Inst. 90(12), 889–905 (1998).
B.M. Fenton, S.F. Paoni, J. Lee, C.J. Koch, and E.M. Lord, Quantification of tumour vasculature and hypoxia by immunohistochemical staining and HbO2 saturation measurements, Br. J. Cancer. 79(3–4), 464–471 (1999).
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2003 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wileyto, E.P., Evans, S.M., Busch, T.M., Koch, C.J. (2003). Quantitative Spatial Analysis of Hypoxia and Vascular Perfusion in Tumor Sections. In: Wilson, D.F., Evans, S.M., Biaglow, J., Pastuszko, A. (eds) Oxygen Transport To Tissue XXIII. Advances in Experimental Medicine and Biology, vol 510. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0205-0_7
Download citation
DOI: https://doi.org/10.1007/978-1-4615-0205-0_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4964-8
Online ISBN: 978-1-4615-0205-0
eBook Packages: Springer Book Archive